enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Cyproheptadine - Wikipedia

   en.wikipedia.org/wiki/Cyproheptadine

   Cyproheptadine, sold under the brand name Periactin among others, is a first-generation antihistamine with additional anticholinergic, antiserotonergic, and local anesthetic properties. It was patented in 1959 and came into medical use in 1961. [ 5 ]

3. Types of PTSD: From Symptoms to Treatment - AOL

   www.aol.com/types-ptsd-symptoms-treatment...

   Complex Post-Traumatic Stress Disorder (CPTSD) Complex PTSD is a form of PTSD that can develop in people who experience ongoing or long-term trauma or multiple traumas. This may include ...

4. Trip killer - Wikipedia

   en.wikipedia.org/wiki/Trip_killer

   Cyproheptadine, a non-selective serotonin receptor antagonist (including of the serotonin 5-HT 2A receptor), is used as an antidote in the treatment of serotonin syndrome (or serotonin toxicity) caused by serotonergic drugs, including the toxicity of serotonergic psychedelics like the NBOMe drugs.

5. Treatments for PTSD - Wikipedia

   en.wikipedia.org/wiki/Treatments_for_PTSD

   Evidence-based, trauma-focused psychotherapy is the first-line treatment for PTSD. [8] [9] [6] Psychotherapy is defined as a treatment where a therapist and patient build a therapeutic relationship and focus on the patient's thoughts, attitudes, affect, behavior, and social development to lessen the patient's psychopathologies and functional impairment.

6. Psychedelic treatments for trauma-related disorders - Wikipedia

   en.wikipedia.org/wiki/Psychedelic_treatments_for...

   Psychotherapy is an effective treatment for trauma-related disorders. A meta-analysis of treatment outcomes has shown that 67% of patients who completed treatment for PTSD no longer met diagnostic criteria for PTSD. [4] For those seeking evidence-based psychotherapy treatment, it is estimated that 22-24% will drop out of their treatment.

7. Psychedelic drug MDMA rejected as treatment for PTSD ... - AOL

   www.aol.com/psychedelic-drug-mdma-rejected...

   In June, the FDA's Psychopharmacologic Drugs Advisory Committeevoted 9-2 against MDMA as an effective treatment for PTSD patients, and 10-1 that the drug's benefits do not outweigh the risks.